Financhill
Back

Global Blood Therapeutics Stock Price Chart

Buy
71

GBT
Global Blood Therapeutics

Last Price:
67.01
Seasonality Move:
-5.93%

7 Day Trial

ALL ACCESS PASS

$ 7
  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GBT is experiencing selling pressure, which indicates risk of future bearish movement.

Global Blood Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 66.4 Buy
20-day SMA: 47.54 Buy
50-day SMA: 36.73 Buy
200-day SMA: 32.08 Buy
8-day EMA: 62.69 Buy
20-day EMA: 52.21 Buy
50-day EMA: 41.58 Buy
200-day EMA: 34.26 Buy

Global Blood Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.62 Buy
Relative Strength Index (14 RSI): 90.05 Buy
Chaikin Money Flow: -2492796 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (30.14 - 59.98) Buy
Bollinger Bands (100): (23.22 - 44.52) Buy

Global Blood Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Global Blood Therapeutics Stock

Is Global Blood Therapeutics Stock a Buy?

GBT Technical Analysis vs Fundamental Analysis

Buy
71
Global Blood Therapeutics (GBT) is a Buy

Is Global Blood Therapeutics a Buy or a Sell?

Global Blood Therapeutics Stock Info

Market Cap:
4.52B
Price in USD:
67.00
Share Volume:
4.79M

Global Blood Therapeutics 52-Week Range

52-Week High:
73.02
52-Week Low:
21.65
Buy
71
Global Blood Therapeutics (GBT) is a Buy

Global Blood Therapeutics Share Price Forecast

Is Global Blood Therapeutics Stock a Buy?

Fundamental Analysis of Global Blood Therapeutics

Is Global Blood Therapeutics a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.22 per share, and an increase next year of $1.81 per share.

Technical Analysis of Global Blood Therapeutics

Should I short Global Blood Therapeutics stock?

* Global Blood Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.